Download FREE Report Sample
Download Free sampleEffective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.
Attention Deficit Hyperactivity Disorder Market contains market size and forecasts of Attention Deficit Hyperactivity Disorder (ADHD) in Global, including the following market information:
Global Attention Deficit Hyperactivity Disorder (ADHD) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Attention Deficit Hyperactivity Disorder (ADHD) market was valued at 12590 million in 2021 and is projected to reach US$ 19460 million by 2028, at a CAGR of 6.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stimulant Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Attention Deficit Hyperactivity Disorder (ADHD) include Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals and Noven Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Attention Deficit Hyperactivity Disorder (ADHD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Attention Deficit Hyperactivity Disorder (ADHD) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Attention Deficit Hyperactivity Disorder (ADHD) Market Segment Percentages, by Type, 2021 (%)
Stimulant
Non-stimulant
Global Attention Deficit Hyperactivity Disorder (ADHD) Market, by Distribution Channel, 2017-2022, 2023-2028 ($ millions)
Global Attention Deficit Hyperactivity Disorder (ADHD) Market Segment Percentages, by Distribution Channel, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Global Attention Deficit Hyperactivity Disorder (ADHD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Attention Deficit Hyperactivity Disorder (ADHD) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Attention Deficit Hyperactivity Disorder (ADHD) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Attention Deficit Hyperactivity Disorder (ADHD) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
